Technology | Sudden Cardiac Arrest | December 22, 2015

FDA Approved Pediatric Indication for Zoll's LifeVest Wearable Cardioverter Defibrillator

zoll lifevest

December 22, 2015 - The U.S. Food and Drug Administration has cleared the Zoll LifeVest Wearable Cardioverter Defibrillator, Models 3000, 3100, and 4000, for the additional indication treating pediatric patients 

The Zoll LifeVest is a wearable cardioverter defibrillator to monitor and treat dangerous, abnormally fast heart rhythms. These life threatening arrhythmias can lead to a complete absence of heartbeat (sudden cardiac arrest) and death (sudden cardiac death) if they are not treated. This device was first approved for patients 18 years of age and over in 2001, and it is now available for children. Patients under the age of 18 must have a chest circumference of 26 inches and weigh at least 18.75 kg (approximately 43 pounds, the average size of an 8-year-old).

The LifeVest system consists of two main components, an electrode belt that fits within a lightweight garment worn on the patient's chest, and a monitor and alarm that the patient wears around the waist. The system continuously monitors a patient's heartbeat. If it detects an abnormally fast heartbeat (ventricular tachycardia), or if the system detects an abnormally irregular heartbeat (ventricular fibrillation), it delivers a high-energy shock. 

When the device detects an abnormal heart rhythm, an alarm sequence begins, giving a patient time to stop the treatment if it is not necessary. The patient can prevent a shock by simultaneously pressing two response buttons. If the patient does not respond to the alarm or releases the response buttons, the device continues to alarm and gives a verbal warning that a treatment shock is about to be delivered. Just before a shock is delivered, blue gel within the electrodes is released so the shock will be given efficiently.

For more information:

Related Content

The Zoll LifeVest wearable defibrillator was the subject of the VEST Trial

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year.

Feature | Defibrillator Monitors | July 10, 2018 | Michael J. Mirro, M.D.
Following the...
Rice University Students Improve AED Operation With Needle Pad

The automated external defibrillator add-on developed by Rice University students is a pad of needles that break through the skin's natural impedance barrier to deliver an electric shock to the heart of a patient in cardiac arrest. (Credit: Jeff Fitlow/Rice University)

News | Defibrillator Monitors | April 16, 2018
The skin presents a formidable barrier to life-saving defibrillators, but a team of students from Rice University...
Zoll Canada Equipping Province of Québec Paramedic Services with X Series Monitor/Defibrillators
News | Defibrillator Monitors | October 16, 2017
October 16, 2017 — Zoll Canada, a subsidiary of Zoll Medical Corp., announced it has won the tender to equip all ambu
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors | April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors | March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
Philips, FDA, class I recall, HeartStart MRx Monitor/Defibrillator
News | Defibrillator Monitors | March 28, 2017
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart...
Zoll, Hospital Wearable Defibrillator, HWD, FDA premarket approval
Technology | Defibrillator Monitors | March 10, 2017
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket...
Zoll LifeVest wearable defibrillator, WEARIT-II Registry results, CardioStim EuroPace 2016
News | Defibrillator Monitors | June 21, 2016
Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest...
defibrillator-monitors, defibrillator monitor

Physio-Control's LifePAK15

Feature | Defibrillator Monitors | February 03, 2014 | Dave Fornell
For U.S. hospitals and emergency medical services (EMS) looking to upgrade their aging defibrillator-monitors, new...
Overlay Init